Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Open accessThe DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Abstract
Highlights ► Virus-like particles (VLPs) are a class of recombinant subunit vaccines. ► VLPs resemble native viruses but lack infectious genetic material. ► VLPs are promising vaccines due to strong immunogenicity and safety. ► VLPs can be produced in prokaryotic or eukaryotic expression systems, or in vitro. ► VLP-based vaccine candidates targeting many diseases are in clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–240 of 240
Sabara, M. I. J., Parker, M. L., Aha, P. M., Cosco, C., Gibbons, E., Parsons, S., & Babiuk, L. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6994-6997.1991 · Cited by 50
Zhan, X., Slobod, K. S., Krishnamurthy, S., Luque, L. E., Takimoto, T., Jones, B. G., Surman, S. L., Russell, C. J., Portner, A., & Hurwitz, J. L. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.022 · Cited by 50
Liu, W., Jiang, H., Zhou, J., Yang, X., Tang, Y., Fang, D., & Jiang, L. (2009) · Virus Genes · doi:10.1007/s11262-009-0418-2 · Cited by 49
Peters, B. S., CHEINGSONG-POPOV, R., Callow, D., Foxall, R. B., Patou, G., Hodgkin, K., & Weber, J. N. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)92814-0 · Cited by 48
Phelps, J. P., Dang, N., & Rasochová, L. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2006.12.008 · Cited by 48
Saldaña, S., Esquivel-Guadarrama, F. R., Olivera-Flores, T. D. J., Arias, N., López, S., Arias, C. F., Ruíz‐Medrano, R., Mason, H. S., Mor, T. S., Richter, L., et al. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.42 · Cited by 46
Jaffray, A. E., Shephard, E., Harmelen, J. H. V., Williamson, C. E., Williamson, A., & Rybicki, E. P. (2004) · Journal of General Virology · doi:10.1099/vir.0.19396-0 · Cited by 45
Synthesis of rotavirus-like particles in insect cells: Comparative and quantitative analysis
Jiang, B., Barniak, V. L., Smith, R. P., Sharma, R., Corsaro, B. G., Hu, B. T., & MADORE, H. P. (1998) · Biotechnology and Bioengineering · Cited by 43
Thönes, N., & Müller, M. (2007) · Virology · doi:10.1016/j.virol.2007.08.004 · Cited by 43
Hsieh, S., Liu, I.-J., King, C., Chang, G. J., & Wang, W. (2008) · Virology · doi:10.1016/j.virol.2007.12.041 · Cited by 43
Soulié, J. C., Devillier, P., Santarelli, J., Goudeau, A., Vermeulen, P., Guellier, M., Saliou, P., Hillion, A. M., Tron, F., & Huchet, J. (1991) · Vaccine · doi:10.1016/0264-410x(91)90240-7 · Cited by 43
Yerushalmi, B., Raz, R., Blondheim, O., SHUMOV, E., Koren, R., & Dagan, R. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199706000-00009 · Cited by 42
Hsieh, S., Tsai, W.-Y., & Wang, W. (2010) · Journal of Virology · doi:10.1128/jvi.01963-09 · Cited by 42
Theoretical studies of viral capsid proteins
Phelps, D. K. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00064-6 · Cited by 41
Cusi, M. G., Zurbriggen, R., Correale, P., Valassina, M., Terrosi, C., Pergola, L., Valensin, P. E., & Glück, R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00353-5 · Cited by 40
Krammer, F., Nakowitsch, S., Messner, P., Palmberger, D., Ferko, B., & Grabherr, R. M. (2009) · Biotechnology Journal · doi:10.1002/biot.200900267 · Cited by 40
Virus-like particle based vaccines for Alzheimer disease
Chackerian, B. (2010) · Human Vaccines · doi:10.4161/hv.6.11.12655 · Cited by 40
Christensen, J., Alexandersen, S., Bloch, B., Aasted, B., & Uttenthal, Å. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-1-149 · Cited by 39
Mapping of a Region of Ebola Virus VP40 That Is Important in the Production of Virus‐Like Particles
Yamayoshi, S., & Kawaoka, Y. (2007) · The Journal of Infectious Diseases · doi:10.1086/520595 · Cited by 35
Pearton, M., Kang, S., Song, J. M., Anstey, A. V., Ivory, M. O., Compans, R. W., & Birchall, J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012410 · Cited by 34
Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig
Jeoung, H.-Y., Lee, W., Jeong, W., Shin, B., Choi, H., Lee, H. S., & An, D.-J. (2011) · Virology Journal · doi:10.1186/1743-422x-8-170 · Cited by 34
Milich, D. R., Hughes, J. L., Jones, J. E., Sällberg, M., & Phillips, T. R. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00400-5 · Cited by 33
CD40L-Containing Virus-Like Particle as a Candidate HIV-1 Vaccine Targeting Dendritic Cells
Franco, D., Liu, W., Gardiner, D., Hahn, B. H., & Ho, D. D. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31820b844e · Cited by 33
Assateerawatt, A., Tanphaichitr, V. S., Suvatte, V., & Yodthong, S. (1993) · PubMed · Cited by 32
Notka, F., Stahl‐Hennig, C., Dittmer, U., Wolf, H. J., & Wagner, R. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00200-5 · Cited by 32
Winblad, B. G., Minthon, L., Floesser, A., Imbert, G., Dumortier, T., He, Y., Maguire, P., Karlsson, M., Östlund, H., Lundmark, J., et al. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.356 · Cited by 32
Halsey, R. J., Tanzer, F. L., Meyers, A. E., Pillay, S., Lynch, A. G., Shephard, E., Williamson, A., & Rybicki, E. P. (2008) · Virus Research · doi:10.1016/j.virusres.2008.01.012 · Cited by 30
Nuzzaci, M., Vitti, A., Condelli, V., Lanorte, M. T., Tortorella, C., Boscia, D., Piazzolla, P., & Piazzolla, G. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.01.021 · Cited by 30
Sharon, B., & Schleiss, M. R. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181c1b2a0 · Cited by 29
Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease
Vitti, A., Piazzolla, G., Condelli, V., Nuzzaci, M., Lanorte, M. T., Boscia, D., Stradis, A. D., Antonaci, S., Piazzolla, P., & Tortorella, C. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.07.039 · Cited by 27
Yang, Y., Li, X., Yang, H. M., Qian, Y., Zhang, Y., Fang, R., & Chen, X. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4104-3 · Cited by 26
Zhou, H., Guo, L., Wang, M., Qu, J., Zhao, Z., Wang, J., & Hung, T. (2011) · Virology Journal · doi:10.1186/1743-422x-8-3 · Cited by 26
Ko, Y.-J., Choi, K.-S., Nah, J., Paton, D. J., Oem, J., Wilsden, G., Kang, S., Jo, N.-I., Lee, J.-H., Kim, J., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.8.922-929.2005 · Cited by 25
Morrison, T. G. (2010) · Future Virology · doi:10.2217/fvl.10.50 · Cited by 24
Powilleit, F., Breinig, T., & Schmitt, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000415 · Cited by 20
O2‐05‐03: Immunotherapy targeting abnormal protein conformation
Wısnıewskı, T., Prelli, F. C., Scholtzova, H., Chung, E., Mehta, P. D., Kascsak, R., Kascsak, R. J., & Goñi, F. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.354 · Cited by 20
Nallet, S., Amacker, M., Westerfeld, N., Baldi, L., König, I., Hacker, D. L., Zaborosch, C., Zurbriggen, R., & Wurm, F. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.019 · Cited by 18
Pan, Y.-S., Wei, H.-J., Chang, C.-C., Lin, C.-H., Wei, T.-S., Wu, S., & Chang, D. (2010) · BioMed Research International · doi:10.1155/2010/506363 · Cited by 17
Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches
Scotti, N., Buonaguro, L., Tornesello, M. L., Cardi, T., & Buonaguro, L. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.79 · Cited by 15
Reconstitution of hepatitis B surface antigen proteins into phospholipid vesicles
Gómez‐Gutiérrez, J., Rodríguez‐Crespo, I., Peterson, D. L., et al. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90141-4 · Cited by 13
Cited by
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.014 · Cited by 555
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P. M., & Toth, I. (2013) · ChemMedChem · doi:10.1002/cmdc.201200487 · Cited by 464
Ma, J., Bruce, T. J., Jones, E. M., & Cain, K. D. (2019) · Microorganisms · doi:10.3390/microorganisms7110569 · Cited by 424
Bioengineering virus‐like particles as vaccines
Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25159 · Cited by 355
Metadata
- Authors
- Kushnir, N., Streatfield, S. J., & Yusibov, V.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 31
- Issue
- 1
- Pages
- 58-83
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2120321866
- Cited by
- 587
- References
- 240
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.